Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Munch, E. Taudorf, B. Weeke (1982)
Dose frequency in the treatment of asthmatics with inhaled topical steroid.European journal of respiratory diseases. Supplement, 122
A. Lahdensuo, K. Alanko, H. Poppins, M. Härkönen (1974)
A comparative study of the efficacy of inhaled beclomethasone and systemic prednisolone in bronchial asthma.Scandinavian journal of respiratory diseases, 55 6
J. Björkander, H. Formgren, Johansson Sa, E. Millqvist (1982)
Methodological aspects on clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma.European journal of respiratory diseases. Supplement, 122
J. Nuutinen, P. Ruoppi, M. Sorri, J. Suonpää, J. Vainio-Mattila (1983)
Two-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis.Rhinology, 21 2
J. Toogood, J. Baskerville, Barbara Jennings, N. Lefcoe, S. Johansson (1982)
Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide.The Journal of allergy and clinical immunology, 70 4
R. Mecoy, B. Laby (1980)
Beclomethasone diproprionate in twice daily treatment of asthma.Australian family physician, 9 10
E. Munch, G. Gómez, C. Harris, R. LACK, V. Edwards, P. O'Connor, D. Snowden, N. Mygind (1981)
An open comparison of dosage frequencies of beclomethasone dipropionate in seasonal allergic rhinitisClinical & Experimental Allergy, 11
L. Martin, C. Harrison, R. Tanner (1975)
Metabolism of beclomethasone dipropionate by animals and man.Postgraduate medical journal, 51 Suppl 4
228 30 30 3 3 H. Tukiainen J. Vaara E. Terho P. Karttunen M. Silvasti Department of Pulmonary Diseases Kuopio University Central Hospital Kuopio Finland Kuopio Regional Institute of Occupational Health Kuopio Finland Medical Department Orion Corporation Ltd. Remeda Pharmaceutical Kuopio Finland Summary Twice-daily and four-times daily treatment with beclomethasone dipropionate aerosol were compared in a double dummy crossover study in patients with severe chronic bronchial asthma. The trial consisted of two two-month treatment periods preceded by a two-week baseline period. No significant difference was found in the morning or evening PEF, in symptom scores for wheeze, cough, sputum, sleep disturbance, limitation of daily activity, rhinitis, daily usage of bronchodilator aerosol or requirement for additional oral corticosteroids. The study has confirmed that in management of severe bronchial asthma, a twice-daily regimen of beclomethasone dipropionate aerosol is as effective as four-times daily treatment, if the total daily dose of beclomethasone dipropionate is kept unchanged.
European Journal of Clinical Pharmacology – Springer Journals
Published: May 1, 1986
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.